Blockchain Registration Transaction Record

Tonix Pharmaceuticals Collaborates with Makana Therapeutics for Xenotransplantation Research

Tonix Pharmaceuticals partners with Makana Therapeutics to evaluate TNX-1500 in preclinical studies for xenotransplantation, showcasing the potential for groundbreaking advancements in organ failure treatments and human-compatible transplant solutions.

This news matters as it highlights a significant research collaboration between Tonix Pharmaceuticals and Makana Therapeutics to potentially revolutionize organ transplantation solutions, addressing organ failure through innovative approaches. The collaboration signifies a step towards developing compassionate use applications for xenotransplantation, paving the way for advanced treatments in the field of biopharmaceuticals and organ compatibility.